 |
Poster abstract deadline extended
The abstract submission deadline for the European Congress on Biotechnology (ECB2026) has been extended until 24 May 2026. Take this opportunity to present your research or work at one of Europe’s leading biotechnology events. Join us in Antwerp, Belgium, from 28 June to 1 July 2026, and showcase your contributions within one of the following scientific streams:
-
Innovations for healthy living
-
Solutions for a sustainable planet
-
Manufacturing with microbes
-
Feeding the planet
There are still slots available for flash poster and poster presentations.
New submission deadline: 24 May 2026
Early bird registration deadline extended
The early bird registration deadline has been extended until 3 May. Take advantage of this extended period to secure your spot at a reduced rate. Don’t miss this opportunity to join us while benefiting from discounted registration fees!
 |
|
|
 |
Abstract submission deadline: 31 May 2026
The deadline to submit abstracts for the Food Biotechnology Conference is 31 May 2026, with just over one month remaining. Researchers are invited to submit their work for oral or poster presentations. The conference will take place on 8–9 September 2026 in Sion, Switzerland, at HES-SO Valais.
Conference topics include:
-
Sustainable food ingredients through biotechnological innovation
-
Fermentation and upcycling in food systems
-
Microbiome-active foods and health functionality
-
Enabling technologies in Food Biotechnology
-
Ethics, regulation, and societal impact of Food Biotechnology
|
|
|
 |
Abstract submission deadline: 24 May 2026
The deadline to submit abstracts for the 9th Conference on Physiology of Yeasts and Filamentous Fungi (PYFF9) is 24 May 2026. Researchers are invited to submit their work for oral or poster presentations.
The conference will take place on 8–11 September 2026 in Valencia, Spain.
PYFF9 will cover a broad range of topics related to yeast and filamentous fungi, including:
-
Fungal physiology and metabolism
-
Evolution and adaptation
-
Pathogenesis and resistance mechanisms
-
Synthetic biology and systems biology
-
Food and beverage fermentations
-
Cell factories and industrial applications
-
Circular economy and sustainable production
-
Emerging tools and technologies, including AI and data science
|
|
|
 |
Abstract submission deadline: 19 July 2026
The deadline to submit abstracts for the 8th Applied Synthetic Biology in Europe Conference (ASBE8) is 19 July 2026.
Researchers are invited to submit their work for oral or poster presentations. The conference will take place on 4–6 November 2026 at the Whitworth Art Gallery in Manchester, UK.
ASBE8 will focus on applied synthetic biology and its role in addressing global challenges, with sessions covering:
-
Factory – bio-based production, clean growth, alternative feedstocks
-
Pharma – therapeutics, diagnostics, gene editing, bioproduction
-
Farm and field – crops, soil, waste treatment, bioremediation
-
Computational design technologies – proteins, systems, and networks
|
|
|
 |
At ECB2026, the European Congress on Biotechnology, editors will reveal publishing secrets. Please attend the conference and the following session!
Editor session: publishing articles as if we were Nobel Laureates
Your years of hard work have generated sufficient data for publications. However, as a graduate student, postdoctoral researcher or starting faculty member, drafting manuscripts, selecting perfect journals, writing cover letters, and responding to harsh reviews and rejections might mean the beginning of headaches, rather than the preparation for celebration of big achievements. This conference session covers the myth and fact of publishing, including tips for manuscript drafting and revision preparation, explanation of the review process from the angle of reviewers and editors, and advice by current editors and productive authors.
Confirmed panelists and speakers:
-
Tae Seok Moon, an editor of 10 journals, including the editor-in-chief of New Biotechnology (Elsevier), the official journal of European Federation of Biotechnology and Asian Federation of Biotechnology.
-
Alex Munro-Clark, an editor of Trends in Biotechnology (Cell Press), a partner journal of Elsevier and high-impact journal covering research and review articles.
|
|
|
 For more information contact This email address is being protected from spambots. You need JavaScript enabled to view it.
|
 |
Institutional Membership benefits at ECB2026
EFB Institutional Members can benefit from exclusive discounts for the European Congress on Biotechnology - ECB2026 Congress:
-
Reduced registration fees for congress participation
-
Discounted rates for exhibition booths
-
Special conditions for sponsorship opportunities
-
Increased visibility during the congress
-
Opportunity to engage with key stakeholders across academia, industry, and policy
Institutional Members in the ECB2026 Panel Discussion
Institutional Members can gain strong visibility at the ECB2026 Congress through a dedicated panel discussion focused on their role within EFB and in the European biotech landscape. As part of the “Voice of Biotechnology in Europe”, members engage directly with academia, industry, and policymakers, strengthening their presence and contributing to key sector discussions.
|
|
|
|
ANNOUNCEMENTS FROM INSTITUTIONAL MEMBERS |
 |
The EU Biotech Act: Europe’s ambition for biotechnology
Join Director General Sandra Gallina and EuropaBio for a timely webinar on the EU Biotech Act. Explore its goals, regulatory simplification, industrial enablers, and legislative pathway—and ask your questions live. Essential insights for anyone active in biotech. Register now. [+]
|
|
 |
BGI Genomics
BGI Genomics is the world's leading integrated solutions provider of precision medicine, now serving customers in more than 100 countries, involving over 2,300 medical institutions. Relying on cutting-edge sequencing and bioinformatics technology, we provide our customers with expert and affordable clinical molecular diagnostic solutions and high-throughput sequencing (NGS) research services. [+]
|
|
 |
Ready to elevate your screening?
Steady data collection. Seamless decisions. The Kuhner microTOM brings online monitoring directly to 96- or 24-well microtiter plates, tracking oxygen transfer rates for fast, reliable, and automated strain or media optimization. Make data-driven choices quickly — no manual sampling, no offline analysis, and no interruptions. [+]
|
|
 |
Save the date: 10–13 November 2026, Graz, Austria.
The European Summit of Industrial Biotechnology (esib), organized by acib GmbH, is a well-established networking platform event for the community of industrial biotechnology. esib 2026 is held together with the International Conference on Metabolic and Protein Engineering for Biosynthesis (MaPEB) and unites the leading representatives of industry, academia and politics in Graz. Super Early Bird fee is valid until 31 May 2026. Find the full program here: [+]
|
|
 |
Dutch Biotechnology Congress 2026
We are happy to announce the keynote speakers for the Dutch Biotechnology Congress 2026: Prof. Vera Meyer (TU Berlin), Dr. Markus Herrgård (BioInnovation Institute) and Dr. Katelijne Bekers (Microharvest), an exciting line-up which combines state-of-the-art research with societal and commercial impact. Join us Tuesday 22 September 2026 in Jaarbeurs Utrecht! [+]
|
|
 |
Swiss Biotech Day: Meet partners through 1:1 partnering
On 4–5 May 2026, the event will bring together more than 3,000 participants from across the global life sciences ecosystem in Basel. Whether seeking access to new resources, expertise, and markets or aiming to boost innovation, the partnering at this premier global biotechnology conference provides an efficient way to connect with potential partners. Discover the program and secure your participation. [+]
|
|
 |
ESACT Courses 2026
Applications are now open for the highly interactive ESACT courses 2026 in Spain. Designed for students, academic and industrial scientists, the courses offer opportunities to learn about mammalian cells advancements and applications in biotherapeutics, vaccines, cell and gene therapy development and for metabolic and bioprocess modelling. For full course details, eligibility criteria, and applications info, please visit our website. [+]
|
|
 |
iBET’s bioprocess to expand hiPSC-derived cardiomyocytes for cell therapy recognized by European Commission Innovation Radar
This robust and scalable bioprocess enables billion-scale expansion of hiPSC-derived cardiomyocytes in controlled bioreactors. Developed within the EU-funded BRAV3 project, it supports reproducible, cost-effective large-scale manufacturing, delivering clinically relevant cell numbers with consistent quality/functionality. This platform also applies to preclinical disease modelling/drug screening/cardiotoxicity assessment. [+]
|
|
|
|
|
|
